How Drug-Industry Lobbyists Got Their Way on Health Care

It's understandable the drugmakers would want a roll-call accounting of who their friends and enemies are, considering the size of the investment they are making on Capitol Hill: in the first six months of this year alone, drug and biotech companies and their trade associations spent more than $110 million — that's about $609,000 a day — to influence lawmakers, according to figures compiled by the nonpartisan watchdog group Center for Responsive ... Full Story »

Posted by Kaizar Campwala - via Ellen Miller, Huffington Post (Health Care)

See All Reviews »

To:


Separate email addresses with commas.
25 recipients max.

Note:

Review

N638965977_3994_thumb
3.4
by Ben Ross - Oct. 27, 2009

Takes a while to get the info across...leaves out facts which many would like to keep hidden. Not bad for TIME....does not mention any history of patent law history or intent.

(11 answers)

Ben's Rating

Overall
3.4

Average
from 11 answers
Quality
3.4
Facts
4.0
Fairness
3.0
Sourcing
3.0
Style
4.0
Context
3.0
Depth
3.0
Enterprise
4.0
Relevance
4.0
Popularity
3.5
Recommendation
4.0
Credibility
3.0
More How our ratings work »